<DOC>
	<DOCNO>NCT00724542</DOCNO>
	<brief_summary>The purpose study determine whether therapeutic intervention impair glucose tolerance patient coronary heart disease decrease incidence new onset DM .</brief_summary>
	<brief_title>Evaluation Intervention Impaired Glucose Tolerance ( IGT ) Patients With Coronary Heart Disease .</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Voglibose</mesh_term>
	<criteria>Patients coronary heart disease Impaired Glucose Tolerance Age &lt; 40yr &gt; 75yr Diabetes Mellitus Scr &gt; 2.0 mg/dL（176 μmol/L） ALT AST &gt; 2.5 ULN Hb &lt; 90g/L Heart Failure Infection Undergo interventional clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>